Compare SVRA & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SVRA | MMI |
|---|---|---|
| Founded | 2007 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | N/A | 2013 |
| Metric | SVRA | MMI |
|---|---|---|
| Price | $5.58 | $28.16 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 9 | 2 |
| Target Price | $7.33 | ★ $29.00 |
| AVG Volume (30 Days) | ★ 3.5M | 474.0K |
| Earning Date | 11-12-2025 | 02-13-2026 |
| Dividend Yield | N/A | ★ 1.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $751,284,000.00 |
| Revenue This Year | N/A | $11.94 |
| Revenue Next Year | N/A | $15.59 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 20.74 |
| 52 Week Low | $1.89 | $26.87 |
| 52 Week High | $7.01 | $41.94 |
| Indicator | SVRA | MMI |
|---|---|---|
| Relative Strength Index (RSI) | 41.85 | 50.93 |
| Support Level | $5.47 | $26.87 |
| Resistance Level | $6.64 | $27.65 |
| Average True Range (ATR) | 0.35 | 0.60 |
| MACD | -0.17 | 0.07 |
| Stochastic Oscillator | 7.60 | 92.47 |
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.